CO24 Daratumumab in Combination with Lenalidomide and Dexamethasone Improves Survival in Newly Diagnosed Transplant-Ineligible Multiple Myeloma: A Parametric Network Meta-Analysis in a United Kingdom Setting
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.097
https://www.valueinhealthjournal.com/article/S1098-3015(23)03227-8/fulltext
Title :
CO24 Daratumumab in Combination with Lenalidomide and Dexamethasone Improves Survival in Newly Diagnosed Transplant-Ineligible Multiple Myeloma: A Parametric Network Meta-Analysis in a United Kingdom Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03227-8&doi=10.1016/j.jval.2023.09.097
First page :
Section Title :
Open access? :
No
Section Order :
10413